Breaking News Instant updates and real-time market news.

BIOS

BioScrip

$1.78

-0.05 (-2.73%)

04:55
04/17/19
04/17
04:55
04/17/19
04:55

BioScrip management to meet with Barrington

Meeting to be held in Chicago on April 17 hosted by Barrington.

  • 17

    Apr

  • 28

    May

  • 13

    Nov

BIOS BioScrip
$1.78

-0.05 (-2.73%)

03/18/19
SPHN
03/18/19
DOWNGRADE
Target $3.5
SPHN
Equal Weight
BioScrip downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Dana Hambly downgraded BioScrip Equal Weight from Overweight and lowered his price target for the shares to $3.50 from $5.00. The company "surprised the market" by announcing a merger with Option Care, Hambly tells investors in a research note. While there are "attractive elements" to the combined entity, these will materialize over "several more years," Hambly tells investors in a research note. Over the nearer term, the analyst does not see many catalysts and is concerned with "levered transformational deals." However, he expects BioScrip shares to move higher this week, with management on the road selling the deal, and settle into the $3.00-$3.50 range.
03/18/19
LSCM
03/18/19
NO CHANGE
Target $3.5
LSCM
Buy
BioScrip outlook positive following 'unexpected' merger, say Lake Street
Lake Street analyst Brooks O'Neil says BioScrip's outlook remains positive despite Friday's "disappointing" Q4 results and "unexpected" all-stock merger with Option Care. The combined company can deliver high single digit revenue growth and in the range of $175M of 2019 adjusted EBITDA pre- synergies, O'Neil tells investors in a research note. Further, while management has committed to $60M of synergies, the analyst thinks "there could be much more, certainly over several years." His analysis can get to a $3.50 per share valuation for BioScrip "without stretching too far." O'Neil keeps a Buy rating on the stock with a $3.50 price target.
03/18/19
03/18/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Facebook (FB) downgraded to Hold from Buy at Needham with analyst Laura Martin citing three factors that she sees creating a "negative network effect," namely its strategic pivot toward privacy and encrypted messages, the growing risks of regulation and "horrific" events like those recently in New Zealand that hurt Facebook's brand and are difficult to block from the service at a 100% level. 2. Quest Diagnostics (DGX) downgraded to Neutral from Outperform at Credit Suisse. 3. Aramark (ARMK) downgraded to Neutral from Buy at Nomura Instinet with analyst Dan Dolev saying while the company's "significant scale" in North America should drive consistent 5%-plus organic growth, "execution mishaps and inability to win sufficient new business" resulted in just 2%-3% organic growth versus 7%-8% for main competitor Compass. 4. BioScrip (BIOS) downgraded to Equal Weight from Overweight at Stephens with analyst Dana Hambly saying the company "surprised the market" by announcing a merger with Option Care. 5. PVH Corp. (PVH) assumed with a Neutral from Buy at Citi with analyst Paul Lejuez saying while PVH has two brands with good global growth potential in Tommy Hilfiger and Calvin Klein, the company overall is still heavily dependent on the North America wholesale and outlet channels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/18/19
ADAM
03/18/19
NO CHANGE
Target $3.5
ADAM
Buy
Canaccord, while disappointed with merger terms, remains buyer of BioScrip
Canaccord Genuity analyst Richard Close lowered his price target for BioScrip to $3.50 from $5.00 while reiterating a Buy rating on the shares. While disappointed with the terms of the Option Care merger agreement as BioScrip shareholders are just 20% shareholders post-transaction, the analyst says he understands the rationale for the merger. The need for scale in healthcare is "increasingly paramount as the provider and payer markets consolidate and reimbursement risk is always present," Close tells investors in a research note titled "Merger: short-term pain but long-term." Longer-term scale matters and the transaction provides an improved capital structure, says the analyst. He remains a buyer of BioScrip shares.

TODAY'S FREE FLY STORIES

16:40
04/18/19
04/18
16:40
04/18/19
16:40
General news
Fed Balance Sheet Level data reported »

Week of 4/17 Fed Balance…

16:40
04/18/19
04/18
16:40
04/18/19
16:40
General news
Money Supply M2 Weekly Change data reported »

Week of 4/8 Money Supply…

BLK

BlackRock

$465.67

-1.99 (-0.43%)

16:38
04/18/19
04/18
16:38
04/18/19
16:38
Hot Stocks
BlackRock CFO sells 2,750 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 27

    Oct

TRV

Travelers

$138.82

2.93 (2.16%)

, HON

Honeywell

$169.01

6.09 (3.74%)

16:38
04/18/19
04/18
16:38
04/18/19
16:38
On The Fly
Fly Intel: Wall Street's top stories for Thursday »

The S&P 500 notched a…

TRV

Travelers

$138.82

2.93 (2.16%)

HON

Honeywell

$169.01

6.09 (3.74%)

AXP

American Express

$113.67

1.89 (1.69%)

PM

Philip Morris

$84.53

-0.96 (-1.12%)

ZM

Zoom Video

$62.00

(0.00%)

PINS

Pinterest

$24.46

(0.00%)

CGC

Canopy Growth

$44.43

1.6 (3.74%)

ACRGF

Acreage Holdings

$0.00

(0.00%)

FB

Facebook

$178.28

-0.49 (-0.27%)

BX

Blackstone

$38.65

2.74 (7.63%)

ADTN

Adtran

$16.60

2.055 (14.13%)

URI

United Rentals

$136.05

10.25 (8.15%)

CHKP

Check Point

$120.01

-9.56 (-7.38%)

SNBR

Sleep Number

$39.23

-8.76 (-18.25%)

SKX

Skechers

$31.60

-3.68 (-10.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 18

    Apr

  • 24

    Apr

  • 24

    Apr

  • 29

    Apr

  • 01

    May

  • 06

    May

  • 07

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 14

    May

  • 14

    May

  • 15

    May

  • 17

    May

  • 18

    May

  • 03

    Jun

  • 05

    Jun

  • 11

    Jun

  • 13

    Nov

  • 18

    Apr

  • 18

    Apr

GBCI

Glacier Bancorp

$41.70

-0.7 (-1.65%)

16:36
04/18/19
04/18
16:36
04/18/19
16:36
Earnings
Glacier Bancorp reports Q1 EPS 58c, consensus 58c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 24

    Apr

BLMN

Bloomin' Brands

$19.24

0.42 (2.23%)

16:34
04/18/19
04/18
16:34
04/18/19
16:34
Recommendations
Bloomin' Brands analyst commentary at Tigress Financial »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

APHA

Aphria

$7.65

-0.165 (-2.11%)

16:32
04/18/19
04/18
16:32
04/18/19
16:32
Hot Stocks
Aphria subsidiary secures cannabis cultivation license in Germany »

Aphria Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNP

CenterPoint Energy

$30.29

0.28 (0.93%)

, SO

Southern Company

$51.95

-0.22 (-0.42%)

16:32
04/18/19
04/18
16:32
04/18/19
16:32
Hot Stocks
CenterPoint Energy names Xia Liu as CFO, effective April 22 »

CenterPoint Energy (CNP)…

CNP

CenterPoint Energy

$30.29

0.28 (0.93%)

SO

Southern Company

$51.95

-0.22 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 01

    May

  • 09

    May

  • 21

    May

  • 21

    May

BANF

BancFirst

$55.58

-0.34 (-0.61%)

16:30
04/18/19
04/18
16:30
04/18/19
16:30
Earnings
BancFirst reports Q1 EPS 96c, consensus 92c »

At March 31, 2019, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
04/18/19
04/18
16:30
04/18/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

ZSAN

Zosano Pharma

$3.41

-0.11 (-3.13%)

16:28
04/18/19
04/18
16:28
04/18/19
16:28
Hot Stocks
Zosano Pharma CEO buys 100K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$31.46

-0.16 (-0.51%)

16:26
04/18/19
04/18
16:26
04/18/19
16:26
Hot Stocks
Elizabethtown Gas files rate case with NJBPU »

Elizabethtown Gas, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

BCBP

BCB Bancorp

$13.09

0.08 (0.61%)

16:21
04/18/19
04/18
16:21
04/18/19
16:21
Earnings
BCB Bancorp reports Q1 EPS 32c, consensus 30c »

Total cash and cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
04/18/19
04/18
16:20
04/18/19
16:20
Options
Closing CBOE SPX and VIX Index summary for April 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKE

Oneok

$69.13

-0.59 (-0.85%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Hot Stocks
Oneok increases quarterly dividend 9% to 86.5c per share »

Oneok increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 22

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
04/18/19
04/18
16:17
04/18/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEP

Holly Energy Partners

$28.23

0.51 (1.84%)

16:16
04/18/19
04/18
16:16
04/18/19
16:16
Hot Stocks
Holly Energy Partners raises dividend to 67c per unit from 66.75c »

The distribution will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

HES

Hess Corp.

$65.87

-0.05 (-0.08%)

16:15
04/18/19
04/18
16:15
04/18/19
16:15
Hot Stocks
Hess Corp. announces 13th discovery offshore Guyana »

Hess Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 22

    May

  • 29

    May

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/17 Fed Balance…

16:15
04/18/19
04/18
16:15
04/18/19
16:15
General news
Breaking General news story  »

Week of 4/8 Money Supply…

DTRM

Determine

$0.00

(0.00%)

16:13
04/18/19
04/18
16:13
04/18/19
16:13
Hot Stocks
Determine announces winding up, liquidation, and dissolution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$10.67

-0.08 (-0.74%)

16:12
04/18/19
04/18
16:12
04/18/19
16:12
Hot Stocks
Prothena will explore potential business development opportunities for NEOD001 »

Prothena reports results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

FFIN

First Financial

$60.25

-0.32 (-0.53%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
First Financial reports Q1 EPS 56c, consensus 56c »

Reports Q1 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

INDB

Independent Bank

$84.23

-0.98 (-1.15%)

16:11
04/18/19
04/18
16:11
04/18/19
16:11
Earnings
Independent Bank reports Q1 EPS $1.30, consensus $1.29 »

Reports Q1 NII $82.5M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Apr

  • 13

    May

  • 16

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.